Breaking News Instant updates and real-time market news.

BIIB

Biogen

$243.90 /

+1.85 (+0.76%)

, SAGE

Sage Therapeutics

$76.04 /

-6.57 (-7.95%)

07:45
11/30/20
11/30
07:45
11/30/20
07:45

Sage Therapeutics to hold a business news update conference call

Sage Therapeutics discusses the global collaboration with Biogen to jointly develop and commercialize potential breakthrough therapies in depression and movement disorders on a conference call to be held on November 30 at 8 am. Webcast Link

BIIB

Biogen

$243.90 /

+1.85 (+0.76%)

SAGE

Sage Therapeutics

$76.04 /

-6.57 (-7.95%)

  • 30

    Nov

  • 30

    Nov

  • 07

    Mar

BIIB Biogen
$243.90 /

+1.85 (+0.76%)

11/27/20 Stifel
Stifel says license deal 'good' for Biogen, takes some upside off table for Sage
11/10/20 Truist
Truist raises Biogen price target to $443, views aducanumab approval as 'likely'
11/10/20 DZ Bank
Biogen upgraded to Buy from Hold at DZ Bank
11/09/20 BMO Capital
Biogen price target lowered to $253 from $343 at BMO Capital
SAGE Sage Therapeutics
$76.04 /

-6.57 (-7.95%)

11/19/20 Oppenheimer
Sage Therapeutics price target raised to $94 from $65 at Oppenheimer
11/16/20
Fly Intel: Top five analyst downgrades
11/16/20 Morgan Stanley
Morgan Stanley downgrades Sage Therapeutics amid 'reasonable' expectations

TODAY'S FREE FLY STORIES

Hot Stocks
Myovant Sciences, Pfizer report 'positive' results from Phase 3 SPIRIT study » 06:56
01/26/21
01/26
06:56
01/26/21
06:56
MYOV

Myovant Sciences

$20.73 /

-0.16 (-0.77%)

, PFE

Pfizer

$37.28 /

+0.74 (+2.03%)

Myovant Sciences (MYOV)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MYOV Myovant Sciences
$20.73 /

-0.16 (-0.77%)

PFE Pfizer
$37.28 /

+0.74 (+2.03%)

MYOV Myovant Sciences
$20.73 /

-0.16 (-0.77%)

01/08/21 SVB Leerink
Myovant Sciences downgraded to Market Perform from Outperform at SVB Leerink
01/06/21 Goldman Sachs
Myovant Sciences downgraded to Neutral from Buy at Goldman Sachs
12/29/20 Citi
Citi boosts Myovant target to $30 on 'smart deal' with Pfizer
12/29/20 Baird
Baird positive on Myovant Sciences deal announcement with Pfizer
PFE Pfizer
$37.28 /

+0.74 (+2.03%)

01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
01/05/21 Argus
Viatris initiated with a Hold at Argus
12/31/20 Ladenburg
UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg
MYOV Myovant Sciences
$20.73 /

-0.16 (-0.77%)

PFE Pfizer
$37.28 /

+0.74 (+2.03%)

PFE Pfizer
$37.28 /

+0.74 (+2.03%)

MYOV Myovant Sciences
$20.73 /

-0.16 (-0.77%)

PFE Pfizer
$37.28 /

+0.74 (+2.03%)

PFE Pfizer
$37.28 /

+0.74 (+2.03%)

Upgrade
Dollar General upgraded to Buy from Hold at Loop Capital » 06:56
01/26/21
01/26
06:56
01/26/21
06:56
DG

Dollar General

$206.42 /

+0.08 (+0.04%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DG Dollar General
$206.42 /

+0.08 (+0.04%)

DG Dollar General
$206.42 /

+0.08 (+0.04%)

05:45 Today Loop Capital
Dollar General upgraded to Buy from Hold at Loop Capital
12/04/20 Loop Capital
Dollar General price target raised to $220 from $210 at Loop Capital
12/04/20 BMO Capital
Dollar General price target raised to $240 from $223 at BMO Capital
12/04/20 Citi
Dollar General price target raised to $250 from $235 at Citi
DG Dollar General
$206.42 /

+0.08 (+0.04%)

DG Dollar General
$206.42 /

+0.08 (+0.04%)

DG Dollar General
$206.42 /

+0.08 (+0.04%)

Hot Stocks
Comscore announces partnership agreement with Strong Automotive Merchandising » 06:55
01/26/21
01/26
06:55
01/26/21
06:55
SCOR

Comscore

$3.40 /

-0.03 (-0.87%)

Comscore announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCOR Comscore
$3.40 /

-0.03 (-0.87%)

SCOR Comscore
$3.40 /

-0.03 (-0.87%)

01/11/21 Loop Capital
Comscore upgraded to Buy from Hold at Loop Capital
01/11/21 Loop Capital
Comscore upgraded to Buy from Hold at Loop Capital
08/19/20 Truist
Comscore most likely to remain independent, says Truist
SCOR Comscore
$3.40 /

-0.03 (-0.87%)

SCOR Comscore
$3.40 /

-0.03 (-0.87%)

SCOR Comscore
$3.40 /

-0.03 (-0.87%)

Recommendations
Square short- and long-term setup 'remains impressive,' says Barclays » 06:55
01/26/21
01/26
06:55
01/26/21
06:55
SQ

Square

/

+

Square's mobile app…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SQ Square
/

+

SQ Square
/

+

01/14/21 Evercore ISI
Square price target raised to $304 on Cash App strength at Evercore ISI
01/07/21 Mizuho
Rising bitcoin prices 'boon' to Square revenue, says Mizuho
01/06/21 Truist
Square price target raised to $300 from $250 at Truist
12/24/20 Stephens
Stephens says Tidal deal would show Square 'ambition' beyond most expectations
SQ Square
/

+

SQ Square
/

+

SQ Square
/

+

SQ Square
/

+

Upgrade
Comcast upgraded to Buy from Hold at TD Securities » 06:55
01/26/21
01/26
06:55
01/26/21
06:55
CMCSA

Comcast

$48.98 /

+0.35 (+0.72%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMCSA Comcast
$48.98 /

+0.35 (+0.72%)

CMCSA Comcast
$48.98 /

+0.35 (+0.72%)

06:52 Today TD Securities
Comcast upgraded to Buy from Hold at TD Securities
01/19/21 Barclays
Comcast price target raised to $53 from $48 at Barclays
01/14/21 Macquarie
Comcast price target raised to $58 from $53 at Macquarie
12/16/20 Morgan Stanley
Morgan Stanley names Comcast a top pick, raises price target to $62
CMCSA Comcast
$48.98 /

+0.35 (+0.72%)

CMCSA Comcast
$48.98 /

+0.35 (+0.72%)

CMCSA Comcast
$48.98 /

+0.35 (+0.72%)

CMCSA Comcast
$48.98 /

+0.35 (+0.72%)

General news
FX Update: The dollar rose and then ebbed » 06:55
01/26/21
01/26
06:55
01/26/21
06:55

FX Update: The dollar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Eli Lilly announces BLAZE-1 trial meets primary endpoint » 06:54
01/26/21
01/26
06:54
01/26/21
06:54
LLY

Eli Lilly

$212.52 /

+6.22 (+3.02%)

Bamlanivimab 2800 mg and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

01/20/21 Citi
Citi opens 'positive Catalyst Watch' on Eli Lilly into Alzheimer's data
01/19/21 Roth Capital
Merus price target raised to $32 from $19 at Roth Capital
01/19/21
Fly Intel: Top five analyst upgrades
01/19/21 Mizuho
Eli Lilly upgraded to Buy from Neutral at Mizuho
LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

Upgrade
Comcast upgraded to Buy from Hold at TD Securities » 06:52
01/26/21
01/26
06:52
01/26/21
06:52
CMCSA

Comcast

$48.98 /

+0.35 (+0.72%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CMCSA Comcast
$48.98 /

+0.35 (+0.72%)

CMCSA Comcast
$48.98 /

+0.35 (+0.72%)

01/19/21 Barclays
Comcast price target raised to $53 from $48 at Barclays
01/14/21 Macquarie
Comcast price target raised to $58 from $53 at Macquarie
12/16/20 Morgan Stanley
Morgan Stanley names Comcast a top pick, raises price target to $62
11/25/20 TD Securities
Comcast downgraded to Hold after recent rally at TD Securities
CMCSA Comcast
$48.98 /

+0.35 (+0.72%)

CMCSA Comcast
$48.98 /

+0.35 (+0.72%)

CMCSA Comcast
$48.98 /

+0.35 (+0.72%)

CMCSA Comcast
$48.98 /

+0.35 (+0.72%)

Recommendations
Macom price target raised to $65 from $52 at Barclays » 06:52
01/26/21
01/26
06:52
01/26/21
06:52
MTSI

Macom

/

+

Barclays analyst Thomas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MTSI Macom
/

+

MTSI Macom
/

+

01/13/21 Piper Sandler
Macom price target raised to $70 from $60 at Piper Sandler
01/13/21 Piper Sandler
AMD price target raised to $110 from $100 at Piper Sandler
01/11/21 BofA
Macom upgraded to Buy from Underperform at BofA
12/18/20 Piper Sandler
Piper boosts Macom target to $60, calls top small pick for 2021
MTSI Macom
/

+

MTSI Macom
/

+

Downgrade
Morgan Stanley downgrades Hamilton Lane to Equal Weight following outperformance » 06:52
01/26/21
01/26
06:52
01/26/21
06:52
HLNE

Hamilton Lane

/

+

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HLNE Hamilton Lane
/

+

HLNE Hamilton Lane
/

+

05:32 Today Morgan Stanley
Hamilton Lane downgraded to Equal Weight from Overweight at Morgan Stanley
01/11/21 Wells Fargo
Hamilton Lane price target raised to $77 from $70 at Wells Fargo
12/16/20 UBS
Hamilton Lane initiated with a Buy at UBS
09/17/20 Morgan Stanley
Hamilton Lane's recent selloff presents buying opportunity, says Morgan Stanley
HLNE Hamilton Lane
/

+

  • 02
    Sep
  • 03
    Jun
Recommendations
Veeco price target raised to $22 from $15 at Barclays » 06:51
01/26/21
01/26
06:51
01/26/21
06:51
VECO

Veeco

$20.53 /

-0.14 (-0.68%)

Barclays analyst Thomas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VECO Veeco
$20.53 /

-0.14 (-0.68%)

VECO Veeco
$20.53 /

-0.14 (-0.68%)

12/29/20 Goldman Sachs
Veeco price target raised to $18 from $16 at Goldman Sachs
09/17/20 Barclays
Veeco initiated with an Overweight at Barclays
09/15/20 Goldman Sachs
Veeco upgraded to Buy from Neutral at Goldman Sachs
09/09/20 Stifel
Veeco selloff overdone given limited semi exposure in China, says Stifel
VECO Veeco
$20.53 /

-0.14 (-0.68%)

VECO Veeco
$20.53 /

-0.14 (-0.68%)

Recommendations
Texas Instruments price target raised to $155 from $140 at Barclays » 06:51
01/26/21
01/26
06:51
01/26/21
06:51
TXN

Texas Instruments

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TXN Texas Instruments
/

+

TXN Texas Instruments
/

+

01/21/21 Oppenheimer
Texas Instruments price target raised to $185 from $180 at Oppenheimer
01/21/21 Oppenheimer
Texas Instruments price target raised to $185 from $180 at Oppenheimer
12/17/20 Deutsche Bank
Texas Instruments price target raised to $150 from $145 at Deutsche Bank
12/16/20 Citi
Citi sees 'substantial upside' to semi estimates after latest checks
TXN Texas Instruments
/

+

TXN Texas Instruments
/

+

TXN Texas Instruments
/

+

TXN Texas Instruments
/

+

Hot Stocks
Rockwell Automation names Scott Genereux as chief revenue officer » 06:51
01/26/21
01/26
06:51
01/26/21
06:51
ROK

Rockwell Automation

$260.62 /

-5.29 (-1.99%)

Rockwell Automation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROK Rockwell Automation
$260.62 /

-5.29 (-1.99%)

ROK Rockwell Automation
$260.62 /

-5.29 (-1.99%)

01/04/21 Vertical Research
Rockwell Automation upgraded to Hold from Sell at Vertical Research
11/30/20 Barclays
Rockwell Automation downgraded to Equal Weight on valuation at Barclays
11/30/20 Barclays
Rockwell Automation downgraded to Equal Weight from Overweight at Barclays
11/23/20
Fly Intel: Top five analyst upgrades
ROK Rockwell Automation
$260.62 /

-5.29 (-1.99%)

Recommendations
Skyworks price target raised to $165 from $150 at Barclays » 06:51
01/26/21
01/26
06:51
01/26/21
06:51
SWKS

Skyworks

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWKS Skyworks
/

+

SWKS Skyworks
/

+

01/25/21 Citi
Skyworks price target raised to $164 from $137 at Citi
01/11/21 BofA
Skyworks downgraded to Neutral from Buy at BofA
01/06/21 KeyBanc
Skyworks price target raised to $180 from $170 at KeyBanc
12/14/20 Goldman Sachs
Skyworks price target raised to $171 from $162
SWKS Skyworks
/

+

SWKS Skyworks
/

+

SWKS Skyworks
/

+

Recommendations
SiTime price target raised to $150 from $100 at Barclays » 06:50
01/26/21
01/26
06:50
01/26/21
06:50
SITM

SiTime

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SITM SiTime
/

+

SITM SiTime
/

+

12/30/20 Roth Capital
SiTime price target raised to $130 from $110 at Roth Capital
11/25/20 Lynx
SiTime benefiting from October fire at AKM factory in Japan, says Lynx
11/05/20 Needham
SiTime price target raised to $105 from $75 at Needham
10/15/20 Roth Capital
SiTime price target raised to $110 from $80 at Roth Capital
SITM SiTime
/

+

  • 12
    Jun
SITM SiTime
/

+

Recommendations
Silicon Labs price target raised to $150 from $135 at Barclays » 06:50
01/26/21
01/26
06:50
01/26/21
06:50
SLAB

Silicon Labs

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLAB Silicon Labs
/

+

SLAB Silicon Labs
/

+

01/25/21 Citi
Silicon Labs price target raised to $165 from $121 at Citi
01/19/21
Fly Intel: Top five analyst initiations
01/19/21 Morgan Stanley
Silicon Labs initiated with an Equal Weight at Morgan Stanley
12/30/20 Roth Capital
Silicon Labs price target raised to $140 from $120 at Roth Capital
SLAB Silicon Labs
/

+

Recommendations
Qualcomm price target raised to $150 from $135 at Barclays » 06:50
01/26/21
01/26
06:50
01/26/21
06:50
QCOM

Qualcomm

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QCOM Qualcomm
/

+

QCOM Qualcomm
/

+

01/06/21 KeyBanc
Skyworks price target raised to $180 from $170 at KeyBanc
01/06/21 KeyBanc
Qualcomm price target raised to $180 from $175 at KeyBanc
01/05/21 Wells Fargo
Wells Fargo sees 'seamless transition' for new Qualcomm CEO
01/05/21 Canaccord
Qualcomm price target raised to $180 from $175 at Canaccord
QCOM Qualcomm
/

+

QCOM Qualcomm
/

+

QCOM Qualcomm
/

+

QCOM Qualcomm
/

+

Recommendations
Qorvo price target raised to $185 from $160 at Barclays » 06:50
01/26/21
01/26
06:50
01/26/21
06:50
QRVO

Qorvo

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QRVO Qorvo
/

+

QRVO Qorvo
/

+

01/25/21 Citi
Qorvo price target raised to $188 from $144 at Citi
12/28/20 Mizuho
Qorvo price target raised to $180 from $155 at Mizuho
12/22/20 Benchmark
Qorvo price target raised to $185 from $155 at Benchmark
12/14/20 Goldman Sachs
Qorvo price target raised to $190 from $180 at Goldman Sachs
QRVO Qorvo
/

+

QRVO Qorvo
/

+

QRVO Qorvo
/

+

Earnings
Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 » 06:50
01/26/21
01/26
06:50
01/26/21
06:50
JNJ

Johnson & Johnson

$165.91 /

+2.23 (+1.36%)

Consensus $8.99. Sees…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

Recommendations
NXP Semiconductors price target raised to $200 from $150 at Barclays » 06:50
01/26/21
01/26
06:50
01/26/21
06:50
NXPI

NXP Semiconductors

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NXPI NXP Semiconductors
/

+

NXPI NXP Semiconductors
/

+

01/15/21 Truist
NXP Semiconductors price target raised to $209 from $165 at Truist
01/06/21 KeyBanc
NXP Semiconductors price target raised to $195 from $190 at KeyBanc
12/28/20 Mizuho
NXP Semiconductors price target raised to $173 from $155 at Mizuho
12/17/20 KeyBanc
NXP Semiconductors price target raised to $190 from $160 at KeyBanc
NXPI NXP Semiconductors
/

+

NXPI NXP Semiconductors
/

+

NXPI NXP Semiconductors
/

+

Hot Stocks
Genmab reports $4.109B in worldwide net trade sales of Darzalex in 2020 » 06:49
01/26/21
01/26
06:49
01/26/21
06:49
GMAB

Genmab

$42.68 /

-0.41 (-0.95%)

, JNJ

Johnson & Johnson

$165.91 /

+2.23 (+1.36%)

Genmab (GMAB) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GMAB Genmab
$42.68 /

-0.41 (-0.95%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

GMAB Genmab
$42.68 /

-0.41 (-0.95%)

01/25/21 DNB Markets
Genmab downgraded to Sell from Hold at DNB Markets
01/19/21 Morgan Stanley
Genmab downgraded to Equal Weight on valuation at Morgan Stanley
01/19/21 Morgan Stanley
Genmab downgraded to Equal Weight from Overweight at Morgan Stanley
01/15/21 H.C. Wainwright
Genmab price target raised to $49 from $44 at H.C. Wainwright
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

Recommendations
Nvidia price target raised to $600 from $550 at Barclays » 06:49
01/26/21
01/26
06:49
01/26/21
06:49
NVDA

Nvidia

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVDA Nvidia
/

+

NVDA Nvidia
/

+

01/25/21 Citi
Citi moves Marvell up to pick in semiconductor equipment
01/15/21 Truist
Nvidia price target raised to $672 from $643 at Truist
01/15/21 Susquehanna
Nvidia price target raised to $625 from $610 at Susquehanna
01/12/21 Wells Fargo
Nvidia very-well positioned as gaming momentum continues, says Wells Fargo
NVDA Nvidia
/

+

NVDA Nvidia
/

+

NVDA Nvidia
/

+

NVDA Nvidia
/

+

Recommendations
Maxim Integrated price target raised to $95 from $74 at Barclays » 06:49
01/26/21
01/26
06:49
01/26/21
06:49
MXIM

Maxim Integrated

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MXIM Maxim Integrated
/

+

MXIM Maxim Integrated
/

+

01/25/21 Deutsche Bank
Maxim Integrated price target raised to $101 from $95 at Deutsche Bank
12/17/20 Deutsche Bank
Maxim Integrated price target raised to $95 from $90 at Deutsche Bank
11/25/20 Truist
Analog Devices price target raised to $164 from $136 at Truist
08/20/20 RBC Capital
Analog Devices price target raised to $135 from $130 at RBC Capital
MXIM Maxim Integrated
/

+

Recommendations
Marvell price target raised to $60 from $50 at Barclays » 06:49
01/26/21
01/26
06:49
01/26/21
06:49
MRVL

Marvell

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
/

+

MRVL Marvell
/

+

01/25/21 Citi
Citi moves Marvell up to pick in semiconductor equipment
01/25/21 Citi
Marvell price target raised to $64 from $50 at Citi
01/15/21 Susquehanna
Marvell price target raised to $60 from $54 at Susquehanna
01/13/21 Piper Sandler
Marvell price target raised to $60 from $50 at Piper Sandler
MRVL Marvell
/

+

MRVL Marvell
/

+

MRVL Marvell
/

+

MRVL Marvell
/

+

Recommendations
Lam Research price target raised to $600 from $405 at Barclays » 06:48
01/26/21
01/26
06:48
01/26/21
06:48
LRCX

Lam Research

/

+

Barclays analyst Blayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LRCX Lam Research
/

+

LRCX Lam Research
/

+

01/25/21 B. Riley Securities
Lam Research price target raised to $650 from $600 at B. Riley Securities
01/25/21 Credit Suisse
Lam Research price target raised to $650 from $450 at Credit Suisse
01/25/21 Deutsche Bank
Lam Research price target raised to $575 from $500 at Deutsche Bank
01/25/21 Citi
Citi moves Marvell up to pick in semiconductor equipment
LRCX Lam Research
/

+

LRCX Lam Research
/

+

LRCX Lam Research
/

+

LRCX Lam Research
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.